A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety andEfficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic ObstructivePulmonary Disease (PH-COPD)

Medicine & Life Sciences

1. treprostinil 100%
2. Pulmonary Hypertension 59%
3. Double-Blind Method 59%
4. Placebos 41%
5. Safety 35%
6. Chronic Obstructive Pulmonary Disease 26%
7. Chronic Disease 22%